AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 112 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | -100.0% | 608 | -96.0% | 0.00% | – |
Q1 2022 | $7,000 | -75.0% | 15,096 | -69.3% | 0.00% | – |
Q4 2021 | $28,000 | -34.9% | 49,249 | +88.2% | 0.00% | – |
Q3 2021 | $43,000 | +59.3% | 26,165 | +61.7% | 0.00% | – |
Q2 2021 | $27,000 | +237.5% | 16,186 | +215.8% | 0.00% | – |
Q1 2021 | $8,000 | +60.0% | 5,125 | +64.0% | 0.00% | – |
Q4 2020 | $5,000 | -58.3% | 3,125 | -75.5% | 0.00% | – |
Q3 2020 | $12,000 | +50.0% | 12,742 | 0.0% | 0.00% | – |
Q2 2020 | $8,000 | +700.0% | 12,742 | +688.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 1,617 | -21.1% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 2,050 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 2,050 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 2,050 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 2,050 | -11.2% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 2,309 | -43.7% | 0.00% | – |
Q3 2018 | $2,000 | +100.0% | 4,099 | +583.2% | 0.00% | – |
Q2 2018 | $1,000 | -50.0% | 600 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | 0.0% | 600 | 0.0% | 0.00% | – |
Q4 2017 | $2,000 | – | 600 | +200.0% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 200 | -83.3% | 0.00% | – |
Q2 2017 | $1,000 | -50.0% | 1,200 | -47.9% | 0.00% | – |
Q1 2017 | $2,000 | -33.3% | 2,305 | -17.5% | 0.00% | – |
Q4 2016 | $3,000 | +200.0% | 2,793 | +179.3% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2016 | $2,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2015 | $4,000 | +33.3% | 1,000 | -0.9% | 0.00% | – |
Q3 2015 | $3,000 | +50.0% | 1,009 | 0.0% | 0.00% | – |
Q2 2015 | $2,000 | -86.7% | 1,009 | -49.6% | 0.00% | – |
Q1 2015 | $15,000 | +114.3% | 2,000 | 0.0% | 0.00% | – |
Q4 2014 | $7,000 | -86.3% | 2,000 | -86.2% | 0.00% | – |
Q3 2014 | $51,000 | -60.5% | 14,470 | -6.5% | 0.00% | – |
Q2 2014 | $129,000 | +40.2% | 15,470 | +6.9% | 0.00% | – |
Q1 2014 | $92,000 | -18.6% | 14,470 | -8.8% | 0.00% | – |
Q4 2013 | $113,000 | -26.6% | 15,870 | -22.9% | 0.00% | – |
Q3 2013 | $154,000 | +30.5% | 20,580 | +0.7% | 0.00% | – |
Q2 2013 | $118,000 | – | 20,440 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |